Strategic · Healthtech
AIRS Medical announces strategic growth investment from TA Associates
The undisclosed investment supports international expansion and product development; closing remained conditional at announcement.
Financing context
The June 16 announcement said the transaction was expected to close in the second quarter of 2026, subject to customary conditions. It disclosed no investment amount.
TA’s backing is intended to expand AIRS Medical’s international reach and accelerate its imaging products. At announcement, the company reported more than 1,700 healthcare institutions in over 40 countries and use in more than six million MRI examinations annually. These figures describe the company’s reported deployment base at that time.
Funding history
Strategic · This roundUndisclosed